Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 36

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India

Bakthavatchalam, Yamuna Devi, Babu, Priyanka, Munusamy, Elakkiya, Dwarakanathan, Hariharan Triplicane, Rupali, Priscilla, Zervos, Marcus, John Victor, Peter, Veeraraghavan, Balaji·2019·PLOS ONE

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0227009

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 68

  1. M Melzer, 2003, Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia, Clin Infect Dis, 37, 1453, 10.1086/379321 · DOI · Paper page
  2. A Soriano, 2008, Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia, Clin Infect Dis, 46, 193, 10.1086/524667 · DOI · Paper page
  3. KH Song, 2017, Impact of Vancomycin MIC on Treatment Outcomes in Invasive Staphylococcus aureus Infections, Antimicrob Agents Chemother, 61
  4. HJ Chang, 2012, Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study, J Antimicrob Chemother, 67, 736, 10.1093/jac/dkr531 · doi:10.1093/jac/dkr531
  5. KY Chen, 2013, Relationship of teicoplanin MICs to treatment failure in teicoplanin-treated patients with methicillin-resistant Staphylococcus aureus pneumonia, J Microbiol Immunol Infect, 46, 210, 10.1016/j.jmii.2012.06.010 · DOI
  6. J Cepeda, 2003, Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit, J Antimicrob Chemother, 52, 533, 10.1093/jac/dkg369 · doi:10.1093/jac/dkg369
  7. DM Gomes, 2015, Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus, Pharmacotherapy, 35, 424, 10.1002/phar.1577 · DOI
  8. S Zhang, 2015, Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates, PLoS One, 10, e0136082, 10.1371/journal.pone.0136082 · DOI · Paper page
  9. SJ van Hal, 2011, Vancomycin heteroresistance is associated with reduced mortality in ST239 methicillin-resistant Staphylococcus aureus blood stream infections, PLoS One, 6, e21217, 10.1371/journal.pone.0021217 · DOI
  10. AM Casapao, 2013, Clinical Outcomes in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bloodstream Infection, Antimicrob Agents Chemother, 57, 4252, 10.1128/AAC.00380-13 · DOI
  11. A Dhand, 2014, Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): implications for therapy, F1000 Med Rep, 4, 4
  12. K Hiramatsu, 2001, Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance, Lancet Infect Dis, 1, 147, 10.1016/S1473-3099(01)00091-3 · DOI · Paper page
  13. S Deresinski, 2013, The multiple paths to heteroresistance and intermediate resistance to vancomycin in Staphylococcus aureus, J Infect Dis, 208, 7, 10.1093/infdis/jit136 · DOI
  14. J Xu, 2018, Phenotypic and Molecular Characterisation of Staphylococcus aureus with Reduced Vancomycin Susceptibility Derivated in Vitro, Open Med (Wars), 13, 475, 10.1515/med-2018-0071 · DOI
  15. L Cui, 2006, Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus, Antimicrob Agents Chemother, 50, 428, 10.1128/AAC.50.2.428-438.2006 · DOI · Paper page
  16. S Boyle-Vavra, 2013, VraT/YvqF is required for methicillin resistance and activation of the VraSR regulon in Staphylococcus aureus, Antimicrob Agents Chemother, 57, 83, 10.1128/AAC.01651-12 · DOI
  17. AA Elsaghier, 2002, Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection, J Antimicrob Chemother, 49, 423, 10.1093/jac/49.2.423 · doi:10.1093/jac/49.2.423
  18. K Szymanek-Majchrzak, 2018, Characteristics of glycopeptide-resistant Staphylococcus aureus strains isolated from inpatients of three teaching hospitals in Warsaw, Poland, Antimicrob Resist Infect Control, 7, 105, 10.1186/s13756-018-0397-y · DOI · Paper page
  19. Y Kato, 2010, Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR, J Antimicrob Chemother, 65, 37, 10.1093/jac/dkp394 · DOI
  20. N McCallum, 2010, Regulation of antibiotic resistance in Staphylococcus aureus, Int J Med Microbiol, 300, 118, 10.1016/j.ijmm.2009.08.015 · DOI
  21. H Maki, 2004, tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus, Antimicrob Agents Chemother, 48, 1953, 10.1128/AAC.48.6.1953-1959.2004 · DOI
  22. M Brandenberger, 2000, Inactivation of a novel three-cistronic operon tcaR-tcaA-tcaB increases teicoplanin resistance in Staphylococcus aureus, Biochim Biophys Acta, 1523, 135, 10.1016/S0304-4165(00)00133-1 · DOI
  23. M Wootton, 2005, Expression of tcaA and mprF and glycopeptide resistance in clinical glycopeptide-intermediate Staphylococcus aureus (GISA) and heteroGISA strains, Biochim Biophys Acta, 1726, 326, 10.1016/j.bbagen.2005.09.002 · doi:10.1016/j.bbagen.2005.09.002
  24. C Liu, 2003, Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods, Antimicrob Agents Chemother, 47, 3040, 10.1128/AAC.47.10.3040-3045.2003 · DOI · Paper page
  25. F Brunet, 1990, Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin, Eur J Clin Microbiol Infect Dis, 9, 145, 10.1007/BF01963643 · DOI
  26. K Hiramatsu, 2001, Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance, Lancet Infect Dis, 1, 147, 10.1016/S1473-3099(01)00091-3 · DOI · Paper page
  27. K Sieradzki, 1998, Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci, Antimicrob Agents Chemother, 42, 100, 10.1128/AAC.42.1.100 · doi:10.1128/aac.42.1.100
  28. R Khatib, 2015, Screening for Intermediately Vancomycin-Susceptible and Vancomycin-Heteroresistant Staphylococcus aureus by Use of Vancomycin-Supplemented Brain Heart Infusion Agar Biplates: Defining Growth Interpretation Criteria Based on Gold Standard Confirmation, J Clin Microbiol, 53, 3543, 10.1128/JCM.01620-15 · DOI
  29. SW Satola, 2011, Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method, J Clin Microbiol, 49, 177, 10.1128/JCM.01128-10 · DOI
  30. CA Rodriguez, 2012, Generic vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in a neutropenic mouse thigh infection model, Antimicrob Agents Chemother, 56, 243, 10.1128/AAC.05129-11 · DOI
  31. CJ Chen, 2015, Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia, J Antimicrob Chemother, 70, 2965, 10.1093/jac/dkv225 · DOI
  32. M Goudarzi, 2017, Molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from patients with bacteremia based on MLST, SCCmec, spa, and agr locus types analysis, Microb Pathog, 104, 328, 10.1016/j.micpath.2017.01.055 · doi:10.1016/j.micpath.2017.01.055
  33. K Zhang, 2005, Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus, J Clin Microbiol, 43, 5026, 10.1128/JCM.43.10.5026-5033.2005 · DOI · Paper page
  34. E Ghaznavi-Rad, 2010, A simplified multiplex PCR assay for fast and easy discrimination of globally distributed staphylococcal cassette chromosome mec types in meticillin-resistant Staphylococcus aureus, J Med Microbiol, 59, 1135, 10.1099/jmm.0.021956-0 · doi:10.1099/jmm.0.021956-0
  35. D Harmsen, 2003, Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management, J Clin Microbiol, 41, 5442, 10.1128/JCM.41.12.5442-5448.2003 · DOI · Paper page
  36. MC Enright, 2000, Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus, J Clin Microbiol, 38, 1008, 10.1128/JCM.38.3.1008-1015.2000 · DOI · Paper page
  37. B Ribeiro-Gonçalves, 2016, PHYLOViZ Online: web-based tool for visualization, phylogenetic inference, analysis and sharing of minimum spanning trees, Nucleic Acids Res, 44, W246, 10.1093/nar/gkw359 · DOI · Paper page
  38. A.R. Wattam, 2013, PATRIC, the bacterial bioinformatics database and analysis resource, Nucleic Acids Res, 42, D581, 10.1093/nar/gkt1099 · DOI · Paper page
  39. RK Aziz, 2008, The RAST Server: rapid annotations using subsystems technology, BMC genomics, 9, 75, 10.1186/1471-2164-9-75 · DOI · Paper page
  40. R Overbeek, 2013, The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST), Nucleic acids research, 42, D206, 10.1093/nar/gkt1226 · DOI · Paper page
  41. T Brettin, 2015, RASTtk: a modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes, Scientific reports, 5, 8365, 10.1038/srep08365 · DOI · Paper page
  42. PC Ng, 2001, Predicting deleterious amino acid substitutions, Genome Res, 11, 863, 10.1101/gr.176601 · DOI · Paper page
  43. T Huang, 2010, Prediction of deleterious non-synonymous SNPs based on protein interaction network and hybrid properties, PLoS One, 5, e11900, 10.1371/journal.pone.0011900 · DOI
  44. P Shannon, 2003, Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks, Genome Research, 13, 2498, 10.1101/gr.1239303 · DOI · Paper page
  45. D Szklarczyk, 2015, STRING v10: protein-protein interaction networks, integrated over the tree of life, Nucleic Acids Research, 43, D447, 10.1093/nar/gku1003 · DOI · Paper page
  46. A Renzoni, 2006, Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus, Antimicrob Agents Chemother, 50, 3048, 10.1128/AAC.00113-06 · DOI
  47. KJ Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262 · DOI · Paper page
  48. P Vaudaux, 2002, Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes, Infect Immun, 70, 5428, 10.1128/IAI.70.10.5428-5437.2002 · DOI · Paper page
  49. TP Lodise, 2008, Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin, Antimicrob Agents Chemother, 52, 3315, 10.1128/AAC.00113-08 · DOI · Paper page
  50. G Sakoulas, 2004, Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia, J Clin Microbiol, 42, 2398, 10.1128/JCM.42.6.2398-2402.2004 · DOI · Paper page
  51. YC Yeh, 2012, Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia, J Microbiol Immunol Infect, 45, 214, 10.1016/j.jmii.2011.11.006 · doi:10.1016/j.jmii.2011.11.006
  52. K Hiramatsu, 2014, Vancomycin-intermediate resistance in Staphylococcus aureus, J Glob Antimicrob Resist, 2, 213, 10.1016/j.jgar.2014.04.006 · DOI
  53. JH Song, 2004, Asian Network for Surveillance of Resistant Pathogens Study Group. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin, Antimicrob Agents Chemother, 48, 4926, 10.1128/AAC.48.12.4926-4928.2004 · DOI
  54. CN Chaudhari, 2015, Heterogeneous vancomycin-intermediate among methicillin resistant Staphylococcus aureus, Med J Armed Forces India, 71, 15, 10.1016/j.mjafi.2014.03.008 · DOI
  55. A Singh, 2015, Increasing Trend of Heterogeneous Vancomycin Intermediate Staphylococcus aureus in a Tertiary Care Center of Northern India, Microb Drug Resist, 21, 545, 10.1089/mdr.2015.0004 · DOI
  56. Y Wang, 2017, Novel Mutation Sites in the Development of Vancomycin- Intermediate Resistance in Staphylococcus aureus, Front Microbiol, 7, 2163, 10.3389/fmicb.2016.02163 · DOI
  57. VC Doddangoudar, 2011, Tracking changes in the vraSR and graSR two component regulatory systems during the development and loss of vancomycin non-susceptibility in a clinical isolate, Clin Microbiol Infect, 17, 1268, 10.1111/j.1469-0691.2011.03463.x · DOI
  58. MT Alam, 2014, Dissecting vancomycin-intermediate resistance in Staphylococcus aureus using genome-wide association, Genome Biol Evol, 6, 1174, 10.1093/gbe/evu092 · DOI
  59. JI Yoo, 2013, Prevalence of amino acid changes in the yvqF, vraSR, graSR, and tcaRAB genes from vancomycin intermediate resistant Staphylococcus aureus, J Microbiol, 51, 160, 10.1007/s12275-013-3088-7 · DOI
  60. LC Lin, 2018, Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate Staphylococcus aureus, Infect Drug Resist, 11, 113, 10.2147/IDR.S148335 · doi:10.2147/idr.s148335
  61. C Hafer, 2012, Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus, Antimicrob Agents Chemother, 56, 5845, 10.1128/AAC.01139-12 · DOI
  62. Y Watanabe, 2011, Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus, J Clin Microbiol, 49, 2680, 10.1128/JCM.02144-10 · DOI · Paper page
  63. M Roch, 2014, Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus, Antimicrob Agents Chemother, 58, 5306, 10.1128/AAC.02574-14 · DOI
  64. Q Hu, 2016, Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus, Front Microbiol, 7, 1601
  65. W Gao, 2013, The RpoB H₄₈₁Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus, J Infect Dis, 207, 929, 10.1093/infdis/jis772 · DOI
  66. K Sieradzki, 2003, Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus, J Bacteriol, 185, 7103, 10.1128/JB.185.24.7103-7110.2003 · DOI · Paper page
  67. C Park, 2012, Downregulation of RNAIII in vancomycin-intermediate Staphylococcus aureus strains regardless of the presence of agr mutation, J Med Microbiol, 61, 345, 10.1099/jmm.0.035204-0 · doi:10.1099/jmm.0.035204-0
  68. Y Harigaya, 2011, Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of Staphyloccocus aureus, BMC Infect Dis, 11, 287, 10.1186/1471-2334-11-287 · DOI

Cited by

See all 36

Metadata

Authors
Bakthavatchalam, Y. D., Babu, P., Munusamy, E., Dwarakanathan, H. T., Rupali, P., Zervos, M., John Victor, P., & Veeraraghavan, B.
Venue
PLOS ONE
Published
2019-12-30
Volume
14
Issue
12
Pages
e0227009
ISSN
1932-6203
Cited by
36
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India. https://app.cochat.ai/papers/10.1371/journal.pone.0227009
The paper
Bakthavatchalam, Y. D., Babu, P., Munusamy, E., Dwarakanathan, H. T., Rupali, P., Zervos, M., John Victor, P., & Veeraraghavan, B. (2019). Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India. PLOS ONE. https://doi.org/10.1371/journal.pone.0227009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.